Sign up to save your podcasts
Or
Share A $9 billion biotech deal
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A $9 billion biotech deal
One of the most prominent immunotherapy companies, Juno Therapeutics, announced a deal to be acquired by Celgene. Plus, we dive into the tech renaissance in Pittsburgh and complain about Seattle's bike lanes. Read all our coverage at GeekWire.com.
See omnystudio.com/listener for privacy information.
View all episodes
By GeekWire
4.8
117117 ratings
One of the most prominent immunotherapy companies, Juno Therapeutics, announced a deal to be acquired by Celgene. Plus, we dive into the tech renaissance in Pittsburgh and complain about Seattle's bike lanes. Read all our coverage at GeekWire.com.
See omnystudio.com/listener for privacy information.
More shows like GeekWire
View all
This Week in Startups
1,290 Listeners
WSJ What’s News
4,345 Listeners
Odd Lots
1,967 Listeners
WSJ Tech News Briefing
1,657 Listeners
The Vergecast
3,717 Listeners
The a16z Show
1,093 Listeners
Decoder with Nilay Patel
3,150 Listeners
Masters of Scale
3,976 Listeners
Y Combinator Startup Podcast
228 Listeners
Tech Brew Ride Home
963 Listeners
Big Technology Podcast
508 Listeners
Hard Fork
5,530 Listeners
This Day in AI Podcast
226 Listeners
The AI Daily Brief: Artificial Intelligence News and Analysis
682 Listeners
How I AI
158 Listeners